S. 229

119th Congress

In Committee

DTC Act of 2025

Sponsored byDemocrat:Sen. Durbin, Richard J. [D-IL]IL· Introduced 23 January 2025

9

Cosponsors

2

Actions

0

Amendments

0

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

23 January 2025·1 year ago

Summary

Introduced in Senate · Updated 6 May 2025

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025

This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.

Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.

The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Timeline

2 actions

  1. Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

    23 January 2025 · IntroReferral

  2. Introduced in Senate

    23 January 2025 · IntroReferral

Sponsorship

9 cosponsors

Cosponsors

  • Democrat444%
  • Republican444%
  • Independent111%

Classification

Policy area

Health

Legislative subjects

Administrative law and regulatory proceduresCivil actions and liabilityDepartment of Health and Human ServicesHealth care costs and insuranceMarketing and advertisingPrescription drugs

Cosponsor momentum

Cumulative over time

Cosponsors grew from 8 on 23 January 2025 to 9 on 28 January 2025.

Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.